Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

The True Post icon

Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year. 

Source: CNBC

Share This Article
The newsroom of The True Post.
Leave a Comment